CDH1 and prostate carcinoma: The authors observed that genistein markedly increased the expression of E-cadherin and significantly decreased the expression of the mesenchymal marker vimentin, when applied in low doses to IA8-ARCaP as well as LNCaP/HIF-1a prostate cancer cells (Zhang et al., 2008[144]).